(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLD, CRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network!. Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Shockwave Medical and CRISPR Therapeutics Beat Expectations in Q1 Earnings, Ocular Therapeutix Falls Short

  • May 08th, 2023
  • 456 views

Shockwave Medical, Inc. (Nasdaq: SWAV) reported better-than-expected Q1 earnings, with an EPS of $1.03 versus the consensus estimate of $0.81. In after-hours trading, SWAV is up $10.04 (+3.65%) and is currently trading at $285.00.

On the other hand, CRISPR Therapeutics AG (Nasdaq: CRSP) reported a Q1 loss of $0.67 per share, which was better than the consensus estimate of a loss of $1.70 per share. As a result, in after-hours trading, CRSP is up $0.54 (+0.96%) and is currently trading at $56.50.

Finally, Ocular Therapeutix, Inc. (Nasdaq: OCUL) reported a Q1 loss of $0.39 per share, worse than the consensus estimate of a loss of $0.26 per share. As a result, in after-hours trading, OCUL is down $0.30 (-4.69%) and is currently trading at $6.10.

 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)

Tags

Social Shares

Post Your Comments

Want To Find Some News?

Recent Posts

News By Industries

Tags